Atezolizumab, Etoposide, Carboplatin, Tarlatamab: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 2 1

Conditions being studied

Condition	Trials
Lung cancer	1
Small Cell Carcinoma of Lung	1

Recruiting trials involving Atezolizumab, Etoposide, Carboplatin, Tarlatamab

Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI Treatment
NCT06830694 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Atezolizumab, Etoposide, Carboplatin, Tarlatamab?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.